TY - JOUR
T1 - The Oncology Care Model
T2 - Perspectives From the Centers for Medicare & Medicaid Services and Participating Oncology Practices in Academia and the Community
AU - Kline, Ron
AU - Adelson, Kerin
AU - Kirshner, Jeffrey J.
AU - Strawbridge, Larissa M.
AU - Devita, Marsha
AU - Sinanis, Naralys
AU - Conway, Patrick H.
AU - Basch, Ethan
PY - 2017
Y1 - 2017
N2 - Cancer care delivery in the United States is often fragmented and inefficient, imposing substantial burdens on patients. Costs of cancer care are rising more rapidly than other specialties, with substantial regional differences in quality and cost. The Centers for Medicare & Medicaid Services (CMS) Innovation Center (CMMIS) recently launched the Oncology Care Model (OCM), which uses payment incentives and practice redesign requirements toward the goal of improving quality while controlling costs. As of March 2017, 190 practices were participating, with approximately 3,200 oncologists providing care for approximately 150,000 unique beneficiaries per year (approximately 20% of the Medicare Fee-for-Service population receiving chemotherapy for cancer). This article provides an overview of the program from the CMS perspective, as well as perspectives from two practices implementing OCM: an academic health system (Yale Cancer Center) and a community practice (Hematology Oncology Associates of Central New York). Requirements of OCM, as well as implementation successes, challenges, financial implications, impact on quality, and future visions, are provided from each perspective.
AB - Cancer care delivery in the United States is often fragmented and inefficient, imposing substantial burdens on patients. Costs of cancer care are rising more rapidly than other specialties, with substantial regional differences in quality and cost. The Centers for Medicare & Medicaid Services (CMS) Innovation Center (CMMIS) recently launched the Oncology Care Model (OCM), which uses payment incentives and practice redesign requirements toward the goal of improving quality while controlling costs. As of March 2017, 190 practices were participating, with approximately 3,200 oncologists providing care for approximately 150,000 unique beneficiaries per year (approximately 20% of the Medicare Fee-for-Service population receiving chemotherapy for cancer). This article provides an overview of the program from the CMS perspective, as well as perspectives from two practices implementing OCM: an academic health system (Yale Cancer Center) and a community practice (Hematology Oncology Associates of Central New York). Requirements of OCM, as well as implementation successes, challenges, financial implications, impact on quality, and future visions, are provided from each perspective.
UR - http://www.scopus.com/inward/record.url?scp=85048790596&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85048790596&partnerID=8YFLogxK
U2 - 10.14694/EDBK_174909
DO - 10.14694/EDBK_174909
M3 - Article
C2 - 28561660
AN - SCOPUS:85048790596
SN - 1548-8756
VL - 37
SP - 460
EP - 466
JO - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
JF - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting
ER -